BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10046172)

  • 1. Fu, Mansuripur, and Meystre reply.
    Fu H; Mansuripur M; Meystre P
    Phys Rev Lett; 1992 Mar; 68(9):1441. PubMed ID: 10046172
    [No Abstract]   [Full Text] [Related]  

  • 2. Mansuripur replies.
    Mansuripur M
    Phys Rev Lett; 2013 Feb; 110(8):089405. PubMed ID: 23473213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "Trouble with the Lorentz law of force: incompatibility with special relativity and momentum conservation".
    Khorrami M
    Phys Rev Lett; 2013 Feb; 110(8):089404. PubMed ID: 23473212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on "Trouble with the Lorentz law of force: incompatibility with special relativity and momentum conservation".
    Saldanha PL
    Phys Rev Lett; 2013 Feb; 110(8):089403. PubMed ID: 23473211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on "Trouble with the Lorentz law of force: incompatibility with special relativity and momentum conservation".
    Barnett SM
    Phys Rev Lett; 2013 Feb; 110(8):089402. PubMed ID: 23473210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on "Trouble with the Lorentz law of force: incompatibility with special relativity and momentum conservation".
    Vanzella DA
    Phys Rev Lett; 2013 Feb; 110(8):089401. PubMed ID: 23473209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response to comments by Professor Barandun and Doctor Möhr as well as to the editorial of Professor Straub concerning the article: "HIV epidemic: a study among practitioners in Vaud" by G. Meystre-Augustoni, G. Van Melle, J.P. Chave, J. Martin, N. Billo, M.P. Glauser and P. Francioli (Schweiz. med. Wschr. 1990; 120: 1390-1393)].
    Meystre-Agustoni G; Van Melle G; Chave JP; Martin J; Billo N; Glauser MP; Francioli P
    Schweiz Med Wochenschr; 1990 Dec; 120(51-52):1999. PubMed ID: 2274766
    [No Abstract]   [Full Text] [Related]  

  • 8. Fu and Dudley reply.
    Fu Y; Dudley SC
    Phys Rev Lett; 1993 Jul; 71(3):466. PubMed ID: 10055281
    [No Abstract]   [Full Text] [Related]  

  • 9. Macroscopic spin tunneling and quantum critical behavior of a condensate in a double-well potential.
    Pu H; Zhang W; Meystre P
    Phys Rev Lett; 2002 Aug; 89(9):090401. PubMed ID: 12190381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of fluoropyrimidines].
    Fujita H
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2307-15. PubMed ID: 6437341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiotoxicity of 5-fluorouracil: a question of formulation].
    Lemaire L; Arellano M; Malet-Martino MC; Martino R; De Forni M
    Bull Cancer; 1994 Dec; 81(12):1057-9. PubMed ID: 7742593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of 5-FU in serumand tissues after nebulization in patients with lung cancer.].
    Li X; Yuan C; Sun G; Lu Z
    Zhongguo Fei Ai Za Zhi; 1999 Dec; 2(2):93-4. PubMed ID: 20929639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of a novel 5-fluorouracil (5-FU) derivative to 5-FU in rats.
    Takada K; Yoshikawa H; Muranishi S
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):99-108. PubMed ID: 6867473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preoperative administration of 5-FU emulsion for lymph nodes metastasis of pancreatic carcinoma].
    Kakizaki K; Yamada Y; Yamauchi H
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1679-81. PubMed ID: 1530330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetic studies on continuous intraportal 5-fluorouracil infusion].
    Matsuzaki H; Yamamura T; Hanai A; Oikawa H; Kikuchi K; Seo K; Ozasa T; Akaishi O; Tsukikawa S; Yamaguchi S
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2121-3. PubMed ID: 7944418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-FU and allopurinol: toxicity modulation and phase II results in colon cancer.
    Kroener JF; Saleh F; Howell SB
    Cancer Treat Rep; 1982 May; 66(5):1133-7. PubMed ID: 7083215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect and toxicity of entrapped polysiloxane 5-Fu polycondensate].
    Fu NW; Zhang LS; Quan LP; Guo R
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):415-7. PubMed ID: 3452537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of dihydropyrimidine dehydrogenase on 5-FU pharmacology.
    Diasio RB
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):21-6; discussion 27. PubMed ID: 11219973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of intraportal chemotherapy in terms of administered dose of 5-FU].
    Yamamura T; Matsuzaki H; Tsukikawa S; Akaishi O; Ozasa T; Miyake H; Tanaka K; Seo K; Oikawa H; Hanai A; Kikuchi K; Yamaguchi S
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1461-3. PubMed ID: 8854780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of 5-fluorouracil incorporated in microspheres for peritoneal carcinomatosis--animal experiments].
    Hagiwara A; Takahashi T; Shimotsuma M; Shirasu M; Tsujimoto H; Ohyama T; Ohgaki M; Imanishi T; Yamazaki J; Fujita T
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1638-40. PubMed ID: 7574781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.